摘要
高危非致残性缺血性脑血管事件(high-risk non-disabling ischemic cerebrovascular event,HR-NICE)的早期精准治疗直接影响预后,故日益受到重视。尽管静脉溶栓是目前公认的缺血性卒中最有效的治疗手段,但对其在HR-NICE患者中的疗效,尚存有争议。本文对近年来国内外HR-NICE治疗的最新进展进行综述。
The early and precise treatment of high-risk non-disabling ischemic cerebrovascular event(HR-NICE) has directly influenced on prognosis,and it attracts more attention.Although intravenous thrombolysis is generally acknowledged as the most effective therapy for ischemic stroke,but it is still in dispute for HR-NICE.This article reviews the domestic and abroad progress in HR-NICE in recent years.
出处
《神经病学与神经康复学杂志》
2018年第1期33-37,共5页
Journal of Neurology and Neurorehabilitation
关键词
脑血管事件
高危非致残性缺血性脑血管事件
治疗
Cerebrovascular event
High-risk non-disabling ischemic cerebrovascular event
Therapy
